Form 4: Tenon Medical CEO Reports Stock Transaction
Insider Transaction (Form 4)
Steven M Foster, CEO and President and a Director of Tenon Medical, Inc., reported multiple transactions in common stock on July 31, 2026.
Summary
- Option exercise/conversion: acquired 140,936 Common Stock on July 31, 2026; holds 304,750 after (Direct).
- Tax/exercise-price withholding: disposed of 41,788 Common Stock at $0.20 ($8,274) on August 3, 2026; holds 262,962 after (Direct).
- Option exercise/conversion: disposed of 140,936 Restricted Stock Units on July 31, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Steven M Foster — Director, Officer (CEO and President)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Option exercise/conversion | Common Stock | 140,936 | — | — | 304,750 |
| 2026-08-03 | Tax/exercise-price withholding | Common Stock | 41,788 | $0 | $8.3K | 262,962 |
| 2026-07-31 | Option exercise/conversion | Restricted Stock Units | 140,936 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Option exercise/conversion (140,936 shares) |
| 2026-08-03 | Tax/exercise-price withholding (41,788 shares) |
| 2026-07-31 | Option exercise/conversion (140,936 shares) |
Keywords
insider transaction, Form 4, TNON, Tenon Medical, Inc., neutral, Steven M Foster
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.